The University of Southampton
University of Southampton Institutional Repository

Immune checkpoint inhibitor induced large vessel vasculitis

Immune checkpoint inhibitor induced large vessel vasculitis
Immune checkpoint inhibitor induced large vessel vasculitis

This is a case report of a 67-year-old patient with castration resistant metastatic prostate cancer who developed an immune-mediated large vessel vasculitis following treatment with ipilimumab (anti-CTLA-4) and nivolumab (anti-PD-1).

cancer intervention, immunology, prostate cancer, unwanted effects/adverse reactions, vasculitis
1757-790X
Henderson, Daisy
b7ddc446-ac2e-4d15-ac26-acb08f415abc
Eslamian, Gelareh
72dd05c9-f062-4c2e-a885-57387468e9cd
Poon, Daniel
ac7a326e-ac0d-458a-aa46-4dda40d7e96b
Crabb, Simon
bcd1b566-7677-4f81-8429-3ab0e85f8373
Jones, Robert
ccc0201e-056c-4c4e-b4af-e35a0ee0860c
Sankey, Peter
7319323b-b000-46b4-8cd6-d2d959bf04c2
Kularatne, Bihani
a7b16303-2973-4c54-a6fe-6c4e112f0315
Linch, Mark
c677c64a-517b-4055-9041-085a4db008a0
Josephs, Debra
d29a064e-60b0-4db8-90f8-b1ee7a5cb4c3
Henderson, Daisy
b7ddc446-ac2e-4d15-ac26-acb08f415abc
Eslamian, Gelareh
72dd05c9-f062-4c2e-a885-57387468e9cd
Poon, Daniel
ac7a326e-ac0d-458a-aa46-4dda40d7e96b
Crabb, Simon
bcd1b566-7677-4f81-8429-3ab0e85f8373
Jones, Robert
ccc0201e-056c-4c4e-b4af-e35a0ee0860c
Sankey, Peter
7319323b-b000-46b4-8cd6-d2d959bf04c2
Kularatne, Bihani
a7b16303-2973-4c54-a6fe-6c4e112f0315
Linch, Mark
c677c64a-517b-4055-9041-085a4db008a0
Josephs, Debra
d29a064e-60b0-4db8-90f8-b1ee7a5cb4c3

Henderson, Daisy, Eslamian, Gelareh, Poon, Daniel, Crabb, Simon, Jones, Robert, Sankey, Peter, Kularatne, Bihani, Linch, Mark and Josephs, Debra (2020) Immune checkpoint inhibitor induced large vessel vasculitis. BMJ Case Reports, 13 (5), [e233496]. (doi:10.1136/bcr-2019-233496).

Record type: Article

Abstract

This is a case report of a 67-year-old patient with castration resistant metastatic prostate cancer who developed an immune-mediated large vessel vasculitis following treatment with ipilimumab (anti-CTLA-4) and nivolumab (anti-PD-1).

This record has no associated files available for download.

More information

Accepted/In Press date: 22 February 2020
e-pub ahead of print date: 18 May 2020
Published date: 18 May 2020
Keywords: cancer intervention, immunology, prostate cancer, unwanted effects/adverse reactions, vasculitis

Identifiers

Local EPrints ID: 441135
URI: http://eprints.soton.ac.uk/id/eprint/441135
ISSN: 1757-790X
PURE UUID: 700510ee-8a33-4ac1-9dca-890a11d986f9
ORCID for Simon Crabb: ORCID iD orcid.org/0000-0003-3521-9064

Catalogue record

Date deposited: 02 Jun 2020 16:32
Last modified: 06 Jun 2024 01:41

Export record

Altmetrics

Contributors

Author: Daisy Henderson
Author: Gelareh Eslamian
Author: Daniel Poon
Author: Simon Crabb ORCID iD
Author: Robert Jones
Author: Peter Sankey
Author: Bihani Kularatne
Author: Mark Linch
Author: Debra Josephs

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×